Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
Clinical trial NCT00515632 · COMPLETED
Trial details
- NCT number
- NCT00515632
- Sponsor
- Rheoscience A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2009-07-01
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.